Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options
Complimentary
Released on 5/15/24
Expires on 5/15/25
Program Description
A glaucoma is a heterogeneous group of diseases that has become a significant cause of irreversible blindness worldwide. A glaucoma group of optic neuropathies is characterized by progressive degeneration of retinal ganglion cells. These are central nervous system neurons with cell bodies in the inner retina and axons in the optic nerve. Degeneration of these nerves results in cupping, a characteristic optic disc appearance, and visual loss. The biological basis of glaucoma is poorly understood, and the factors contributing to its progression have not been fully characterized.
Intended Audience
Ophthalmologists, retina specialists, physician assistants, and nurse practitioners in Ophthalmology clinics
Commercial Supporter
This activity is supported by an educational grant from Alcon Vision.
Educational Objectives
Upon completion of the educational activity, participants should be able to:
- Summarize the pathophysiology, risk factors, and screening of glaucoma
- Assess clinical trial data on topical agents in the management of glaucoma
- Appraise clinical trial data on sustained-release drug delivery systems in the management of glaucoma
- Analyze inequities in the diagnosis and management of glaucoma in African-American and Hispanic patients
Accredited Providers
The University of Cincinnati, Amedco, and MedNet have collaborated to design and execute this activity.


Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and MedNet, LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physicians (ACCME) Credit Designation
Designation Statement
Amedco LLC designates this enduring activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses (ANCC) Credit Designation
Designation Statement
Amedco LLC designates this enduring material activity for a maximum of 1.50 ANCC contact hours.
Additional Credit Information
Physician Assistants/Associates
AAPA accepts AMA PRA Category 1 Credit(s)TM for the PRA from organizations accredited by ACCME. Maximum of 1.50 hours.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum of 1.50 hours.
Conflict of Interests Policy
It is the policy of the Amedco to ensure activity content is balanced, independent, objective and based on scientific best-evidence. All persons in a position to control content (i.e., course director, planning committee member and speaker) were required to disclose any relevant financial relationship with a commercial entity relative to the content of his/her presentation.
Every person in a position to control content reported he/she does not have any relevant financial relationships with industry (relative to the content of his/her presentation) to disclose.
Planners and Managers Disclosures
The planners and managers reported the following financial relationships or relationships to products or
devices they or their spouse/life partner have with commercial interests related to the content of this CME
activity:
All relevant relationships have been reviewed and mitigated.
Kamatham A. Naidu, PhD (MedNet), has no relevant financial relationships
Brian Waggoner (MedNet) has no relevant financial relationships to disclose.
Justin Kaiser (Amedco) has no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
It is the policy of the Amedeo to inform each speaker of his/her responsibility to disclose to the attendees when products or procedures discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved) and of any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.
Each speaker reported he/she will notify the audience if/when discussion includes off-label, unlabeled, experimental, and/or investigational (not FDA approved) information or limited use references within the content of his/her presentation.
Disclaimer
The information provided at this educational initiative is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
Non-Endorsement of Products
Amedco do not imply either real or implied endorsement of any product, service, or company referred to in this educational activity.
Faculty
David S. Friedman, MD, MPH, PhD
Albert and Diane Kaneb Professor
Director, Glaucoma Service
Co-Director, Glaucoma Center of Excellence, Massachusetts Eye and Ear
Boston, MA
Dr. Friedman reported that he received consultant fees from Thea Pharmaceuticals and Health Advances LLC. Slides were provided by Janey Wiggs, Inas Aboobakar and Nazlee Zebardast, Tom Johnson, Ian Pitha, and Henry Jampel.
Karen Allison MD, MBA, FACS
Associate Professor of Clinical Ophthalmology
University of Rochester, Flaum Eye Institute
Rochester, NY
Dr. Allison reported no relevant relationships.
Instructions
In order to receive CME/CE credits, participants must complete the pre-assessment questions, post-assessment, and program evaluation. Participants must also score at least 75% on the post-assessment. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Dashboard or Transcript, which you can access at any time.
For information about the accreditation of this program, please contact Justin Kaiser (justin@amedcoe-mail.com; 651-789-3717).
Privacy Policy
Amedco observes privacy and confidentiality of CME/CE information and personal information of CME/CE participants. Third parties receive only aggregated data about CME/CE activities relevant to their interests and/or the activities they support.
Webcast
Time to Complete: 90 minutes
Released: May 15, 2024
Expires: May 15, 2025
Maximum Credits:
1.50 / AMA PRA Category 1 CreditsTM
1.50 / ANCC Contact Hours
Related products
-

Advances in the Understanding of Etiology, Evaluation, and Management of Neurotrophic Keratitis
Read more -

Biosimilars: Implications for Clinical Practice in Inflammatory Bowel Diseases
Read more -

Cataracts: Advances in Imaging, Intraocular Lenses, and Surgical Procedures
Read more -

Emerging Treatment Options for Pustular Psoriasis
Read more




